Cancer Research SABCS  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 7495, October 1, 2009. Published Online First September 22, 2009;
doi: 10.1158/0008-5472.CAN-09-2111
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0008-5472.CAN-09-2111v1
69/19/7495    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Hurst, D. R.
Right arrow Articles by Welch, D. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurst, D. R.
Right arrow Articles by Welch, D. R.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Invasion and Metastasis

Reviews

Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading

Douglas R. Hurst1,5, Mick D. Edmonds1,5 and Danny R. Welch1,2,3,4,5

Departments of 1 Pathology, 2 Cell Biology, 3 Pharmacology/Toxicology, 4 Comprehensive Cancer Center, and 5 National Foundation for Cancer Research - Center for Metastasis Research, University of Alabama at Birmingham, Birmingham, Alabama

Requests for reprints: Danny R. Welch, Department of Pathology, 1670 University Boulevard, room VH-G019, Birmingham, AL 35294-0019. Phone: 205-934-2961; Fax: 205-975-1126; E-mail: DanWelch{at}uab.edu.

Despite advancements in knowledge from more than a century of metastasis research, the genetic programs and molecular mechanisms required for cancer metastasis are still incompletely understood. Genes that specifically regulate the process of metastasis are useful tools to elucidate molecular mechanisms and may become markers and/or targets for antimetastatic therapy. Recently, several noncoding regulatory RNA genes, microRNA (miRNA), were identified, which play roles in various steps of metastasis, some without obvious roles in tumorigenesis. Understanding how these metastasis-associated miRNA, which we term metastamir, are involved in metastasis will help identify possible biomarkers or targets for the most lethal attribute of cancer: metastasis. [Cancer Res 2009;69(19):7495–8]




This article has been cited by other articles:


Home page
CRO ContentHome page
G. C. Prendergast
Myc Pathway in Cancer: Is the Enigma Yielding?
Cancer Reviews Online Content, January 1, 2009; 2009(11): 21 - 21.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.